New drug combinations of a n.a.r.i., preferably reboxetine,...

Details New drug combinations of a n.a.r.i., preferably reboxetine,... New drug combinations of a n.a.r.i., preferably reboxetine,...

A - Human Necessities

61

K

A61K 31/535 (2006.01)

Patent

CA 2326105

This patent application describes a new combination treatment of selective, noradrenaline-reuptake inhibitors (NARI) and specifically, reboxetine, and pindolol to provide rapid relief to patients suffering from depression, general anxiety, attention deficit hyperactivity disorder (ADHD), anxiety disorders such as obsessive compulsive disorders (OCD), panic disorders (PD), social phobia (SD) and the like.

L'invention concerne une nouveau traitement combiné dans lequel on utilise des d'inhibiteurs sélectifs du recaptage de la noradrénaline (NARI) et spécifiquement, de la reboxétine, et du pindolol, pour soulager rapidement des patients souffrant de dépression, d'anxiété générale, d'hyperactivité avec déficit de l'attention, de troubles de l'anxiété, tels que les troubles obsessivo-compulsifs, de troubles de panique, de phobie sociale et similaire.

Affiliated with

Also associated with

Rating

New drug combinations of a n.a.r.i., preferably reboxetine,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New drug combinations of a n.a.r.i., preferably reboxetine,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New drug combinations of a n.a.r.i., preferably reboxetine,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1436635